Recital 69, Commission Decision of 12/12/2023 declaring a concentration to be compatible with the co…

In forcesince 12 Dec 2023

Nevertheless, there is greater supply side substitutability in the enzymes

distribution market than in the lactase manufacturing market. Entry or expansion in the enzymes distribution market does not require the same type of investments in R&D and equipment to start manufacturing enzymes and described above in section 4.1.2. For instance, an existing expertise in dairy enzymes116 and commercial relationships117 is an asset to start distributing another dairy enzyme.

However, as pointed out by the Parties, what matters most is general enzyme knowledge and an existing commercial network: “generally for distributors with a commercial network and basic enzyme expertise the costs of entry would be limited”.

118 Therefore, the barriers to entry for an established enzyme distributor to start distributing another enzyme, are limited.